Therapeutic Potential for FGFR Inhibitors in SOX9-FGFR2 Coexpressing Pancreatic Cancer

Pancreas. 2017 Sep;46(8):e67-e69. doi: 10.1097/MPA.0000000000000870.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Pancreatic Ductal / drug therapy
  • Carcinoma, Pancreatic Ductal / metabolism*
  • Humans
  • Immunohistochemistry
  • Pancreatic Neoplasms / drug therapy
  • Pancreatic Neoplasms / metabolism*
  • Protein Kinase Inhibitors / therapeutic use
  • Receptor, Fibroblast Growth Factor, Type 2 / biosynthesis*
  • Receptors, Fibroblast Growth Factor / antagonists & inhibitors
  • Receptors, Fibroblast Growth Factor / metabolism
  • SOX9 Transcription Factor / biosynthesis*

Substances

  • Protein Kinase Inhibitors
  • Receptors, Fibroblast Growth Factor
  • SOX9 Transcription Factor
  • SOX9 protein, human
  • FGFR2 protein, human
  • Receptor, Fibroblast Growth Factor, Type 2